In July, SHINE was one of three companies to receive $15 million in funding from the Department of Energy (DOE)’s National Nuclear Security Administration to bolster its production of molybdenum-99 (Mo-99).

Rates of hypertension have been climbing in the U.S. in recent years, according to an analysis by Blue Cross Blue Shield, and they’re growing fastest among millennials and adults in their mid-thirties and forties.

Heart disease deaths are on the rise in the U.S., according to research published in the Journal of the American Medical Association Aug. 27—and they have been for almost a decade.

PLANO, TX – Aug. 27, 2019 – NTT DATA Services, a recognized leader in global technology services, today announced a collaboration with Google Cloud to develop next-gen healthcare solutions designed to improve patient experience, while creating more efficient operations and reducing costs for providers and health plans.

Greater left ventricular mass identified on MRI is a better predictor of coronary artery disease-related death and heart failure compared to coronary artery calcium (CAC) scoring, reported authors of a multi-center study published in Radiology.

Physician compensation increased by a median of 2.92% in 2018, according to a new survey from AMGA Consulting. That’s a big jump from the 0.89% increase in compensation the previous year, reflecting that demand for healthcare professionals is driving higher pay.

Oregon Health & Science University will resume its heart transplant services this month after nearly a year of inactivity, the university announced Aug. 26.

Audiovisual radiology reports can provide significant value when used in addition to traditional reports, according to new findings published by the Journal of Digital Imaging.

Quality Interactions' pioneering cultural competency education is ACAP's choice to reduce unconscious bias and improve patient experience for member organizations.

Pharmaceutical, medical device and consumer packaged goods company Johnson & Johnson has been ordered to pay $572 million to the state of Oklahoma after a judge found the company downplayed the dangers of its opioid painkillers and contributed to the opioid overdose epidemic in the state.